150 related articles for article (PubMed ID: 29706651)
1. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
Chang JW; Kuo WH; Lin CM; Chen WL; Chan SH; Chiu MF; Chang IS; Jiang SS; Tsai FY; Chen CH; Huang PH; Chang KJ; Lin KT; Lin SC; Wang MY; Uen YH; Tu CW; Hou MF; Tsai SF; Shen CY; Tung SL; Wang LH
Oncogene; 2018 Jul; 37(30):4137-4150. PubMed ID: 29706651
[TBL] [Abstract][Full Text] [Related]
2. Growth-arrest-specific 7C protein inhibits tumor metastasis via the N-WASP/FAK/F-actin and hnRNP U/β-TrCP/β-catenin pathways in lung cancer.
Tseng RC; Chang JW; Mao JS; Tsai CD; Wu PC; Lin CJ; Lu YL; Liao SY; Cheng HC; Hsu HS; Wang YC
Oncotarget; 2015 Dec; 6(42):44207-21. PubMed ID: 26506240
[TBL] [Abstract][Full Text] [Related]
3. The WASF3-NCKAP1-CYFIP1 Complex Is Essential for Breast Cancer Metastasis.
Teng Y; Qin H; Bahassan A; Bendzunas NG; Kennedy EJ; Cowell JK
Cancer Res; 2016 Sep; 76(17):5133-42. PubMed ID: 27432794
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
5. Twist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.
Yang L; Hou Y; Yuan J; Tang S; Zhang H; Zhu Q; Du YE; Zhou M; Wen S; Xu L; Tang X; Cui X; Liu M
Oncotarget; 2015 Sep; 6(28):25755-69. PubMed ID: 26342198
[TBL] [Abstract][Full Text] [Related]
6. PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.
Shi M; Cao M; Song J; Liu Q; Li H; Meng F; Pan Z; Bai J; Zheng J
Mol Cancer; 2015 Mar; 14():66. PubMed ID: 25888829
[TBL] [Abstract][Full Text] [Related]
7. FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer.
Hamurcu Z; Kahraman N; Ashour A; Ozpolat B
Breast Cancer Res Treat; 2017 Jun; 163(3):485-493. PubMed ID: 28361350
[TBL] [Abstract][Full Text] [Related]
8. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
9. Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.
Sun Q; Lesperance J; Wettersten H; Luterstein E; DeRose YS; Welm A; Cheresh DA; Desgrosellier JS
J Clin Invest; 2018 Jan; 128(1):531-544. PubMed ID: 29227280
[TBL] [Abstract][Full Text] [Related]
10. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
11. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
[TBL] [Abstract][Full Text] [Related]
12. Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.
Gu X; Wang Y; Wang H; Ni Q; Zhang C; Zhu J; Huang W; Xu P; Mao G; Yang S
Med Oncol; 2015 Jul; 32(7):195. PubMed ID: 26033031
[TBL] [Abstract][Full Text] [Related]
13. PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3.
Shen L; Ke Q; Chai J; Zhang C; Qiu L; Peng F; Deng X; Luo Z
Exp Cell Res; 2018 Sep; 370(1):127-136. PubMed ID: 29913153
[TBL] [Abstract][Full Text] [Related]
14. LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodeling.
Liu Y; Wang Z; Huang D; Wu C; Li H; Zhang X; Meng B; Li Z; Zhu T; Yang S; Sun W
Oncotarget; 2017 Feb; 8(6):9513-9524. PubMed ID: 27880729
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
16. Disabled-1 is down-regulated in clinical breast cancer and regulates cell apoptosis through NF-κB/Bcl-2/caspase-9.
Cao RJ; Li K; Xing WY; Du S; Li Q; Zhu XJ; Cui SS
J Cell Mol Med; 2019 Feb; 23(2):1622-1627. PubMed ID: 30484953
[TBL] [Abstract][Full Text] [Related]
17. An EGFR/Src-dependent β4 integrin/FAK complex contributes to malignancy of breast cancer.
Tai YL; Chu PY; Lai IR; Wang MY; Tseng HY; Guan JL; Liou JY; Shen TL
Sci Rep; 2015 Nov; 5():16408. PubMed ID: 26549523
[TBL] [Abstract][Full Text] [Related]
18. Binding of MMP-9-degraded fibronectin to β6 integrin promotes invasion via the FAK-Src-related Erk1/2 and PI3K/Akt/Smad-1/5/8 pathways in breast cancer.
Li W; Liu Z; Zhao C; Zhai L
Oncol Rep; 2015 Sep; 34(3):1345-52. PubMed ID: 26134759
[TBL] [Abstract][Full Text] [Related]
19. Interaction between p53 mutation and a somatic HDMX biomarker better defines metastatic potential in breast cancer.
Grawenda AM; Møller EK; Lam S; Repapi E; Teunisse AF; Alnæs GI; Børresen-Dale AL; Kristensen VN; Goding CR; Jochemsen AG; Edvardsen H; Bond GL
Cancer Res; 2015 Feb; 75(4):698-708. PubMed ID: 25649770
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]